The association between illicit drug use and infectious complications among trauma patients

被引:0
|
作者
V. Agrawal
J. D. Amos
机构
[1] Clinical Research Institute,Methodist Health System
[2] Methodist Dallas Medical Center,Associates in Surgical Acute Care
关键词
Septic Shock; Trauma Patient; Illicit Drug; Infectious Complication; Injury Severity Score;
D O I
暂无
中图分类号
学科分类号
摘要
Management of patients with traumatic injury is a complex endeavor requiring a concerted effort of multi-organ stabilization and prevention of septic shock. Given that traumatic injury is frequently mediated by illicit drug use, which has previously been associated with immune suppression, it is hypothesized that infectious complications may occur more prevalently in this patient population. In this study, we evaluate the incidence of infectious complications in trauma patients who screened positive for illicit drug abuse. The national trauma databank was queried for all patients who underwent laboratory evaluation for drug use between 2002 and 2009 and between 2013 and 2014. Patient demographics, clinical outcomes (injury severity score [ISS], intensive care unit length of stay [ILOS], hospital length of stay [HLOS], mortality, risk-adjusted ILOS [rILOS] or HLOS [rHLOS]) and infectious complications (pneumonia, superficial surgical site infection, organ space infection, deep space surgical site infection and urinary tract infection) were attained. Out of 5,564,821 incidents, 525,052 admissions met the inclusion criteria. Patients were 41 ± 19 years of age and 72 % were male. Patients positive for drug use were 1.1-fold more likely to develop pneumonia, 1.2-fold more likely to develop superficial site infection, and 1.3-fold more likely to develop organ space infection. No statistically significant variations in ILOS, HLOS, rILOS, rHLOS or mortality were noted. Traumatic patients who screen positive for illicit drug use are more likely to develop infectious complications. Therefore, vigilance and appropriate preventative measures should be considered in this unique group of patients.
引用
收藏
页码:447 / 450
页数:3
相关论文
共 50 条
  • [32] PATTERNS OF ILLICIT DRUG USE - AMONG PATIENTS IN AN ADOLESCENT MEDICAL SERVICE
    CHALL, MN
    NEW YORK STATE JOURNAL OF MEDICINE, 1973, 73 (02) : 329 - 331
  • [33] Association and Effects of Trauma, Displacement, and Illicit Drug Use on Psychiatric Illnesses in Khyber Pakhtunkhwa, Pakistan
    Wazir, Muhammad Noman K.
    Fatima, Kaneez
    Ahmad, Hooria R.
    Kakakhel, Susan
    Yusuf, Nowsher
    Wahid, Fakhria
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (02)
  • [34] The association between licit and illicit drug use and sexuality in young Australian women
    Hillier, L
    De Visser, R
    Kavanagh, AM
    McNair, RP
    MEDICAL JOURNAL OF AUSTRALIA, 2003, 179 (06) : 326 - 327
  • [35] Infectious complications in obese patients after trauma
    Bell, Teresa Maria
    Bayt, Demetria R.
    Siedlecki, Charles B.
    Stokes, Samantha M.
    Yoder, Joseph
    Jenkins, Peter
    Fecher, Alison M.
    JOURNAL OF SURGICAL RESEARCH, 2016, 204 (02) : 393 - 397
  • [36] Predictors of Illicit Drug Use Among Prisoners
    Rowell-Cunsolo, Tawandra L.
    Sampong, Stephen A.
    Befus, Montina
    Mukherjee, Dhritiman V.
    Larson, Elaine L.
    SUBSTANCE USE & MISUSE, 2016, 51 (02) : 261 - 267
  • [37] Illicit drug use among hospitality employees
    Pizam, Abraham
    INTERNATIONAL JOURNAL OF HOSPITALITY MANAGEMENT, 2012, 31 (03) : 631 - 632
  • [38] ILLICIT DRUG USE AMONG CANADIAN YOUTH
    SOLURSH, LP
    CLEMENT, WR
    UNWIN, JR
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1968, 98 (16) : 791 - &
  • [39] Relationships Between Illicit Drug Use and Body Mass Index Among Adolescents
    Blackstone, Sarah R.
    Herrmann, Lynn K.
    HEALTH EDUCATION & BEHAVIOR, 2016, 43 (01) : 21 - 24
  • [40] Association between the use of mood stabilizers and risk of trauma among patients with bipolar disorder
    Ng, Vanessa W.
    Man, Kenneth K.
    Gao, Le
    Chan, Esther W.
    Hayes, Joseph F.
    Wong, Ian C.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 150 - 151